Search

Your search keyword '"Tedder, Matthew L."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Tedder, Matthew L." Remove constraint Author: "Tedder, Matthew L."
40 results on '"Tedder, Matthew L."'

Search Results

1. The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes

2. Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement

3. Identification of a DNA methylation episignature for recurrent constellations of embryonic malformations

4. Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

6. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases

7. Identification of DNA methylation episignature for the intellectual developmental disorder, autosomal dominant 21 syndrome, caused by variants in the CTCF gene

8. Clinical findings and a DNA methylation signature in kindreds with alterations in ZNF711

9. The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8

10. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders

11. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases

12. The detection of a strong episignature for Chung-Jansen syndrome, partially overlapping with Börjeson-Forssman-Lehmann and White-Kernohan syndromes

13. Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

14. DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants

15. DNA methylation episignature for Witteveen-Kolk syndrome due to SIN3A haploinsufficiency

16. Episignature Mapping of TRIP12 Provides Functional Insight into Clark–Baraitser Syndrome

17. Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disorders

19. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders

20. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders

21. The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8

22. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders

23. DNA methylation episignature in Gabriele-de Vries syndrome

24. Near complete deletion ofKMT2Din a college student

25. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders

26. Correction: Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders (Genetics in Medicine, (2021), 23, 6, (1065-1074), 10.1038/s41436-020-01096-4)

27. Identification of a DNA Methylation Episignature in the 22q11.2 Deletion Syndrome

29. Near complete deletion of KMT2D in a college student.

30. Discovery of a novel CHD7 CHARGE syndrome variant by integrated omics analyses.

31. Correction: Clinical findings and a DNA methylation signature in kindreds with alterations in ZNF711

33. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders

34. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders

35. Recurrent carotid paragangliomas in a syndromic patient with a heterozygous missense variant in DNA Methyltransferase 3 Alpha.

36. Blepharophimosis with intellectual disability and Helsmoortel-Van Der Aa Syndrome share episignature and phenotype.

37. Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature.

38. DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A / KAT6B variants.

39. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders.

Catalog

Books, media, physical & digital resources